# Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-safety-and-efficacy-of-consolidation-durvalumab-after-chemoradiation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yu Wang,Tao Zhang,Yilin Huang,Wei Li,Jingjing Zhao,Yin Yang,Canjun Li,Lühua Wang,Nan Bi |
| Citations | 105 |
| DOI | 10.1016/j.ijrobp.2021.12.150 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4200010326 |
| PMID | 34963558 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Yu Wang](https://scholariq.org/researchers/yu-wang-2/)

## Paper journal

- [International Journal of Radiation Oncology*Biology*Physics](https://scholariq.org/journals/international-journal-of-radiation-oncology-biology-physics/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.